-+ 0.00%
-+ 0.00%
-+ 0.00%

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Barchart·10/06/2026 01:00:00
Listen to the news

ORION CORPORATION
PRESS RELEASE
6 OCTOBER 2026 at 9.00 EEST
        

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.